Tubiera, Jmee Maxel L.
HRN: 15-63-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2024
CEFTRIAXONE 1G (VIAL)
03/25/2024
04/01/2024
IV
1.9g
OD
T/C PMBO
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes